Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Azra Bozcaarmutlu, Canan Sapmaz, Ömer Bozdoğan, Aysel Kükner, Leyla Kılınç, Salih Tunç Kaya, Oğulcan Talat Özarslan & Didem Ekşioğlu. (2022) The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver. Drug and Chemical Toxicology 45:3, pages 990-998.
Read now
Read now
J. Máchal, O. Hlinomaz, K. Kostolanská, O. Peš, A. Máchalová, Z. Šplíchal, Z. Mot'ovská & J. Juřica. (2020) CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel- or ticagrelor-treated STEMI patients: monocentric study in PRAGUE-18 trial participants. Xenobiotica 50:8, pages 929-938.
Read now
Read now
Shu-Feng Zhou, Jun-Ping Liu & Balram Chowbay. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:2, pages 89-295.
Read now
Read now
Andreas Holstein & Winfried Beil. (2009) Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions. Expert Opinion on Drug Metabolism & Toxicology 5:3, pages 225-241.
Read now
Read now
Li-jun Luo, Xiao Liu, Yan Li, Yang Li & Li Sheng. Characterization of the metabolic contributions of cytochrome P450 isoforms to bicyclol using the relative activity factor method. Journal of Asian Natural Products Research 0:0, pages 1-12.
Read now
Read now
Articles from other publishers (36)
Galal Magdy, Amira A. Al-enna, Fathalla Belal, Ramadan A. El-Domany & Ahmed M. Abdel-Megied. (2024) Quality-by-design optimized RP-HPLC approach for the therapeutic drug monitoring of glibenclamide and fluoxetine in human plasma. Microchemical Journal 201, pages 110548.
Crossref
Crossref
Alessandro Medoro, Daniela Passarella, Donatella Mignogna, Carola Porcile, Emanuele Foderà, Mariano Intrieri, Gennaro Raimo, Pancrazio La Floresta, Claudio Russo & Gennaro Martucci. (2022) Cutaneous Ulcer Caused by Apixaban Treatment Is Resolved after Replacement with Dabigatran. Medicina 58:5, pages 691.
Crossref
Crossref
Rachel Ryu & Mary F. Hebert. 2022. Clinical Pharmacology During Pregnancy. Clinical Pharmacology During Pregnancy
19
46
.
Yousef A. Bin Jardan, Abdul Ahad, Mohammad Raish, Ajaz Ahmad, Mohd Aftab Alam, Abdullah M. Al-Mohizea & Fahad I. Al-Jenoobi. (2021) Assessment of glibenclamide pharmacokinetics in poloxamer 407-induced hyperlipidemic rats. Saudi Pharmaceutical Journal 29:7, pages 719-723.
Crossref
Crossref
Kenta Yoshida, Kazuya Maeda, Akihiko Konagaya & Hiroyuki Kusuhara. (2018) Accurate Estimation of In Vivo Inhibition Constants of Inhibitors and Fraction Metabolized of Substrates with Physiologically Based Pharmacokinetic Drug–Drug Interaction Models Incorporating Parent Drugs and Metabolites of Substrates with Cluster Newton Method. Drug Metabolism and Disposition 46:11, pages 1805-1816.
Crossref
Crossref
Alexander V. LyubimovEugene G. Hrycay & Stelvio M. Bandiera. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
36
.
Rui Li, Yi-an Bi, Anna Vildhede, Renato J. Scialis, Sumathy Mathialagan, Xin Yang, Lisa D. Marroquin, Jian Lin & Manthena V.S. Varma. (2017) Transporter-Mediated Disposition, Clinical Pharmacokinetics and Cholestatic Potential of Glyburide and Its Primary Active Metabolites. Drug Metabolism and Disposition 45:7, pages 737-747.
Crossref
Crossref
Gregory Ondieki, Makafui Nyagblordzro, Siambi Kikete, Rongjia Liang, Lili Wang & Xin He. (2017) Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-18.
Crossref
Crossref
Ajaz Ahmad, Rao Muzaffar A. Khan, Khalid M. Alkharfy, Mohammad Raish, Fahad I. Al-Jenoobi & Abdullah M. Al-Mohizea. (2015) Effects of Thymoquinone on the Pharmacokinetics and Pharmacodynamics of Glibenclamide in a Rat Model. Natural Product Communications 10:8, pages 1934578X1501000.
Crossref
Crossref
Manthena V. S. Varma, Renato J. Scialis, Jian Lin, Yi-An Bi, Charles J. Rotter, Theunis C. Goosen & Xin Yang. (2014) Mechanism-Based Pharmacokinetic Modeling to Evaluate Transporter-Enzyme Interplay in Drug Interactions and Pharmacogenetics of Glyburide. The AAPS Journal 16:4, pages 736-748.
Crossref
Crossref
Alice Ban Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami-Hodjegan & Jashvant D. Unadkat. (2014) Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19. British Journal of Clinical Pharmacology 77:3, pages 554-570.
Crossref
Crossref
C. F. Samer, K. Ing Lorenzini, V. Rollason, Y. Daali & J. A. Desmeules. (2013) Applications of CYP450 Testing in the Clinical Setting. Molecular Diagnosis & Therapy 17:3, pages 165-184.
Crossref
Crossref
Mary F. Hebert. 2013. Clinical Pharmacology During Pregnancy. Clinical Pharmacology During Pregnancy
17
39
.
Hiroyuki Kusuhara, Kenta Yoshida & Yuichi Sugiyama. 2013. Transporters in Drug Development. Transporters in Drug Development
67
97
.
J. G. Coen van Hasselt, Marilee A. Andrew, Mary F. Hebert, Joel Tarning, Paolo Vicini & Donald R. Mattison. (2012)
The status of pharmacometrics in pregnancy: highlights from the 3
rd
American conference on pharmacometrics
. British Journal of Clinical Pharmacology 74:6, pages 932-939.
Crossref
Crossref
J.-M. Nicolas, H. Chanteux, M. Rosa, S. Watanabe & A. Stockis. (2012) Effect of Gemfibrozil on the Metabolism of Brivaracetam In Vitro and in Human Subjects. Drug Metabolism and Disposition 40:8, pages 1466-1472.
Crossref
Crossref
Haiyan Liu, Li Liu, Jia Li, Dan Mei, Ru Duan, Nan Hu, Haifang Guo, Zeyu Zhong & Xiaodong Liu. (2012) Combined Contributions of Impaired Hepatic CYP2C11 and Intestinal Breast Cancer Resistance Protein Activities and Expression to Increased Oral Glibenclamide Exposure in Rats with Streptozotocin-Induced Diabetes Mellitus. Drug Metabolism and Disposition 40:6, pages 1104-1112.
Crossref
Crossref
Aleksi Tornio, Mikko Niemi, Pertti J. Neuvonen & Janne T. Backman. (2012) Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends in Pharmacological Sciences 33:6, pages 312-322.
Crossref
Crossref
Hao Sun & Dennis O. Scott. (2011) Impact of genetic polymorphisms of cytochrome P450 2 C (CYP2C) enzymes on the drug metabolism and design of antidiabetics. Chemico-Biological Interactions 194:2-3, pages 159-167.
Crossref
Crossref
Sabine Klatt, Martin F. Fromm & Jörg König. (2011) Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs. Pharmaceutics 3:4, pages 680-705.
Crossref
Crossref
Shu-Feng Zhou, Zhi-Wei Zhou & Min Huang. (2010) Polymorphisms of human cytochrome P450 2C9 and the functional relevance. Toxicology 278:2, pages 165-188.
Crossref
Crossref
Katrijn Bogman, Mariabeth Silkey, Siew Pheng Chan, Brian Tomlinson & Cornelia Weber. (2010) Influence of CYP2C19 genotype on the pharmacokinetics of R483, a CYP2C19 substrate, in healthy subjects and type 2 diabetes patients. European Journal of Clinical Pharmacology 66:10, pages 1005-1015.
Crossref
Crossref
Leila Chebane, Neda Tavassoli, Haleh Bagheri & Jean-LouisMontastruc. (2010) Hyperglycémies d’origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). Therapies 65:5, pages 447-458.
Crossref
Crossref
Lin Zhou, Yi Zhang, Mary F. Hebert, Jashvant D. Unadkat & Qingcheng Mao. (2010) Increased Glyburide Clearance in the Pregnant Mouse Model. Drug Metabolism and Disposition 38:9, pages 1403-1406.
Crossref
Crossref
Makiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama & Yuichi Sugiyama. (2010) In Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical Parameters. Drug Metabolism and Disposition 38:8, pages 1362-1370.
Crossref
Crossref
H. Shao, X. M. Ren, N. F. Liu, G. M. Chen, W. L. Li, Z. H. Zhai & D. W. Wang. (2010) Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers. Journal of Clinical Pharmacy and Therapeutics 35:3, pages 351-360.
Crossref
Crossref
Lin Zhou, Suresh B. Naraharisetti, Li Liu, Honggang Wang, Yvonne S. Lin, Nina Isoherranen, Jashvant D. Unadkat, Mary F. Hebert & Qingcheng Mao. (2010) Contributions of human cytochrome P450 enzymes to glyburide metabolism. Biopharmaceutics & Drug Disposition 31:4, pages 228-242.
Crossref
Crossref
Eugene G. Hrycay & Stelvio M. Bandiera. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
70
.
Olga L. Zharikova, Valentina M. Fokina, Tatiana N. Nanovskaya, Ronald A. Hill, Donald R. Mattison, Gary D.V. Hankins & Mahmoud S. Ahmed. (2009) Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. Biochemical Pharmacology 78:12, pages 1483-1490.
Crossref
Crossref
Adam B Adamopoulos, George N Sakizlis, Efthimia G Nasothimiou, Ioanna Anastasopoulou, Eugenia Anastasakou, Paraskevi Kotsi, Anastasia Karafoulidou & George S Stergiou. (2009) Do Proton Pump Inhibitors Attenuate the Effect of Aspirin on Platelet Aggregation? A Randomized Crossover Study. Journal of Cardiovascular Pharmacology 54:2, pages 163-168.
Crossref
Crossref
MF Hebert, X Ma, SB Naraharisetti, KM Krudys, JG Umans, GDV Hankins, SN Caritis, M Miodovnik, DR Mattison, JD Unadkat, EJ Kelly, D Blough, C Cobelli, MS Ahmed, WR Snodgrass, DB Carr, TR Easterling & P Vicini. (2009) Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice. Clinical Pharmacology & Therapeutics 85:6, pages 607-614.
Crossref
Crossref
Ying Ao, Jie Chen, Jiang Yue & Ren-Xiu Peng. (2008) Effects of 18α-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats. European Journal of Pharmacology 587:1-3, pages 330-335.
Crossref
Crossref
Lin Zhou, Suresh Babu Naraharisetti, Honggang Wang, Jashvant D. Unadkat, Mary F. Hebert & Qingcheng Mao. (2008) The Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Fetal Distribution of Glyburide in the Pregnant Mouse: An Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Molecular Pharmacology 73:3, pages 949-959.
Crossref
Crossref
Akash Khandelwal, Praveen M. Bahadduri, Cheng Chang, James E. Polli, Peter W. Swaan & Sean Ekins. (2007) Computational Models to Assign Biopharmaceutics Drug Disposition Classification from Molecular Structure. Pharmaceutical Research 24:12, pages 2249-2262.
Crossref
Crossref
Olga L. Zharikova, Selvan Ravindran, Tatiana N. Nanovskaya, Ronald A. Hill, Gary D.V. Hankins & Mahmoud S. Ahmed. (2007) Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon. Biochemical Pharmacology 73:12, pages 2012-2019.
Crossref
Crossref
María José Gómez-Lechón, José Vicente Castell & María Teresa Donato. (2007) Hepatocytes—the choice to investigate drug metabolism and toxicity in man: In vitro variability as a reflection of in vivo. Chemico-Biological Interactions 168:1, pages 30-50.
Crossref
Crossref